Identity
- Trade Name
- Cfas HbA1c FDA UDI
- Generic Name
- Glycated haemoglobin (HbA1c) IVD, calibrator FDA UDI
- Model / Reference
- 4528417190 FDA UDI
Identifiers
- Catalog Number
- 4528417190 FDA UDI
- Primary DI / UDI-DI
- 04015630921096 FDA UDI
- 510(k) Number
- K052101 FDA UDI
- FDA Product Code
- KRZ FDA UDI
- GMDN Term
- Glycated haemoglobin (HbA1c) IVD, calibrator FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 864.8165 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Glycated haemoglobin (HbA1c) IVD, calibrator
Cfas HbA1c by Roche Diagnostics Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Glycated haemoglobin (HbA1c) IVD, calibrator.
- Diazyme — Diazyme Laboratories, Inc.
- Alfa Wassermann — Alfa Wassermann, Inc. · Class II
- Pointe Scientific, Inc. — POINTE SCIENTIFIC, INC. · Class II
- D-10 Dual — Bio-Rad Laboratories · Class II
- HbA1C CAL — Randox Laboratories, Ltd. · Class II
- Chemistry HbA1c Calibrator Kit — Medica Corp. · Class II
- VARIANT II — Bio-Rad Laboratories · Class I
- Trinity Biotech — Primus Corp. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Roche Diagnostics Corp.
Sources (1)
- FDA UDI 2add06ac-a33b-4011-bbce-c8a128429b02 35 fields · synced May 30, 2026